Skip to main content

eFFECTOR Therapeutics, Inc.

EFTRDelisted Jul 19, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001828522

eFFECTOR Therapeutics, Inc. was delisted on Jul 19, 2024; its insiders filed their last Form 4 on Jun 13, 2024; 18 institutions reported holding it in 13F filings for Q2 2024, worth $251.1K in total; no superinvestor held it.

13F holders, Q4 2022

Institutional positions in eFFECTOR Therapeutics, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
30
+3 vs. Q3 2022
Shares held
24.3M
+369.3K (+1.5%) vs. Q3 2022
Total value
$10.4M
−$3.24M (−23.7%) vs. Q3 2022
New holders
4
7 more added
Sold out
1
3 more reduced

Compare with Q3 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting EFTR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2022: 30 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 12 institutionsQ4 2021: 18 institutionsQ1 2022: 19 institutionsQ2 2022: 24 institutionsQ3 2022: 27 institutionsQ4 2022: 30 institutionsQ1 2023: 26 institutionsQ2 2023: 33 institutionsQ3 2023: 29 institutionsQ4 2023: 24 institutionsQ1 2024: 17 institutionsQ2 2024: 18 institutionsQ3 2024: 3 institutionsQ4 2024: 0 institutionsQ1 2025: 1 institutionQ2 2025: 1 institutionQ3 2025: 1 institutionQ4 2025: 1 institutionQ1 2026: 1 institutionQ2 2026: 1 institution
Value heldQ4 2022: $10.4M
Q1 2021: $0Q2 2021: $0Q3 2021: $187.9MQ4 2021: $174.2MQ1 2022: $89.7MQ2 2022: $33.9MQ3 2022: $13.7MQ4 2022: $10.4MQ1 2023: $8.29MQ2 2023: $20.2MQ3 2023: $14.0MQ4 2023: $5.44MQ1 2024: $13.5MQ2 2024: $251.1KQ3 2024: $4.33KQ4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding EFTR and their total value by quarter
QuarterHoldersValue
Q2 20261$0
Q1 20261$0
Q4 20251$0
Q3 20251$0
Q2 20251$0
Q1 20251$0
Q4 20240$0
Q3 20243$4.33K
Q2 202418$251.1K
Q1 202417$13.5M
Q4 202324$5.44M
Q3 202329$14.0M
Q2 202333$20.2M
Q1 202326$8.29M
Q4 202230$10.4M
Q3 202227$13.7M
Q2 202224$33.9M
Q1 202219$89.7M
Q4 202118$174.2M
Q3 202112$187.9M
Q2 20210$0
Q1 20210$0

Institutions, Q4 2022

Shares, value and share of portfolio for each institution holding eFFECTOR Therapeutics, Inc.; share changes are against Q3 2022.

Institutions holding EFTR in Q4 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Sr One Capital Management, LP6,822,114$2.93M1.07%00.0%Unchanged
Abingworth LLP4,822,114$2.06M0.68%00.0%Unchanged
The Column Group LLC4,309,329$1.84M0.61%00.0%Unchanged
Sectoral Asset Management Inc2,382,644$1.02M0.20%00.0%Unchanged
Parallel Advisors, LLC1,693,559$724.2K0.03%00.0%Unchanged
Blackstone Group Inc.1,308,587$559.6K0.00%00.0%Unchanged
OUP Management Co., LLC1,025,697$438.6K0.72%00.0%Unchanged
Evolution Capital Management LLC527,885$225.7K0.78%00.0%Unchanged
Vanguard Group Inc429,043$183.5K0.00%00.0%Unchanged
CI Private Wealth, LLC275,442$117.8K0.00%+275,442New
Renaissance Technologies LLC219,900$94.0K0.00%+24,501+12.5%Added
Geode Capital Management, LLC106,346$45.0K0.00%00.0%Unchanged
Intelligence Driven Advisers, LLC48,768$24.4K0.00%+48,768New
Wescott Financial Advisory Group, LLC40,556$17.3K0.00%−15,000−27.0%Reduced
Two Sigma Investments, LP38,577$16.5K0.00%−8,646−18.3%Reduced
BlackRock Inc.34,766$14.9K0.00%+2,767+8.6%Added
Susquehanna International Group, LLP33,621$14.4K0.00%+33,621New
Resolute Financial, LLC31,000$13.3K0.01%00.0%Unchanged
UBS Group AG26,263$11.3K0.00%+9,705+58.6%Added
Northern Trust Corp25,993$11.1K0.00%00.0%Unchanged
Tower Research Capital LLC (TRC)22,728$10.0K0.00%+6,321+38.5%Added
Millennium Management LLC21,091$9.00K0.00%+5,044+31.4%Added
State Street Corp20,085$8.59K0.00%00.0%Unchanged
We Are One Seven, LLC20,070$8.58K0.00%00.0%Unchanged
Callan Capital, LLC20,000$8.55K0.00%00.0%Unchanged
Simplex Trading, LLC8,598$3.00K0.00%+2,911+51.2%Added
Morgan Stanley6,000$2.57K0.00%−10.0%Reduced
Advisor Group Holdings, Inc.1,500$1.00K0.00%00.0%Unchanged
Wells Fargo & Company74$320.00%+2+2.8%Added
Bank of America Corp48$200.00%+48New
Two Sigma Securities, LLC0$00.00%−16,201−100.0%Sold out